MeiraGTx Holdings plc (MGTX) research

MeiraGTx Holdings plc
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$11.75
As of

MeiraGTx Holdings plc (MGTX): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-23.

As of . Source: SEC EDGAR filings for MGTX. Method and limitations.

SHARE THIS CARD

Share the MGTX intelligence card

A branded snapshot of MGTX: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion MGTX intelligence card preview
Post to X
LIVE TERMINAL

See MGTX live in the terminal

Track MGTX's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live MGTX terminal, free

Active signals for MGTX

FREE, NO ACCOUNT

Every signal on MGTX, as it fires

You are seeing 5 of 24 signals recorded on MGTX since 2026-06-03.

The five above landed across 3 days. The other 19 were recorded on 2 other days. 15 of the 24 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in MGTX (2026Q2)

Manager / securityMarket value% portfolioQoQ
MILLENNIUM MANAGEMENT LLCCUSIP G59665102 · 2026Q2$40.1M0.01%,
D. E. Shaw & Co., Inc.CUSIP G59665102 · 2026Q2$11.5M0.01%,
CITADEL ADVISORS LLCCUSIP G59665102 · 2026Q2$8.8M0.00%,
Point72 Asset Management, L.P.CUSIP G59665102 · 2026Q2$2.7M0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP G59665102 · 2026Q2$389K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, MGTX

MGTX against its peers

MGTX's operating margin of -130.2% ranks in the 25th percentile of 5 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.

MetricMGTXPeer medianPercentilen
Revenue FY81.4M USD168M USD255
Operating margin-130.2%-79.5%255
Net margin-140.3%-78.3%255
Return on equityn/a-47.2%n/a12

Peers (15): REPL, MNKD, RARE, VOR, JBIO, IMTX, MAZE, CRVS, CGEM, MLTX, GLUE, SVRA, KURA, LBRX, DMRA. Left out: ODTX (no annual filing), SPTX (no annual filing), SLBT (no annual filing), AKTS (no annual filing), APMD (no annual filing), OBX (no annual filing), ANL (period gap), LTGO (no annual filing), ATTO (no annual filing), TRAX (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (MGTX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more MGTX signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to MGTXand get the insider, 13F, options, and confluence read in one view.

Open the live MGTX terminal, free